About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Bckdhbem1(IMPC)J
endonuclease-mediated mutation 1, Jackson
MGI:5825325
Summary 3 genotypes


Genotype
MGI:6261963
hm1
Allelic
Composition
Bckdhbem1(IMPC)J/Bckdhbem1(IMPC)J
Genetic
Background
C57BL/6NJ-Bckdhbem1(IMPC)J/Mmjax
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Bckdhbem1(IMPC)J mutation (2 available); any Bckdhb mutation (21 available)
Data Sources
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging




Genotype
MGI:7580699
hm2
Allelic
Composition
Bckdhbem1(IMPC)J/Bckdhbem1(IMPC)J
Genetic
Background
CByJ.B6-Bckdhbem1(IMPC)J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Bckdhbem1(IMPC)J mutation (2 available); any Bckdhb mutation (21 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• all mice die before the end of the first week of life
• following gene therapy via a single temporal vein injection of a AAV8-EF1alpha-hBCKDHB vector (1014 vg/kg) at P0, one of 8 injected mice dies at P26 while the remaining 7 mice survive to >6 months of age with no apparent defects (2 of these 7 survive to 12 months with good control of plasma leucine levels and a normal hindlimb test)

growth/size/body
• mice that survive to P5 display severe growth delay
• neonatal AAV8-EF1alpha-hBCKDHB gene therapy restores the growth (weight) of both sexes to control values up to P196

homeostasis/metabolism
• mice show a striking increase in plasma levels of the branched-chain amino acids (BCAA) valine, leucine and alloisoleucine at P1, along with a decrease in alanine levels resulting in a high leucine/alanine ratio
• neonatal AAV8-EF1alpha-hBCKDHB gene therapy reduces plasma BCAA levels to less than 2-fold above normal until 6 months of age and alloisoleucine is not detectable
• mice show a significant decrease in plasma alanine levels at P1
• mice show a significant increase in plasma leucine levels at P1
• mice show a significant increase in plasma valine levels at P1
• mice show absence of branched-chain 2-ketoacid dehydrogenase (BCKD) activity in the liver at P1
• neonatal gene therapy increases liver BCKD activity to 16 +/- 8 % and 17 +/- 1 % the values of age-matched untreated wild-type controls at 6 and 12 months, respectively

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
maple syrup urine disease DOID:9269 OMIM:246900
OMIM:248600
OMIM:615135
J:344897




Genotype
MGI:6261962
ht3
Allelic
Composition
Bckdhbem1(IMPC)J/Bckdhb+
Genetic
Background
C57BL/6NJ-Bckdhbem1(IMPC)J/Mmjax
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Bckdhbem1(IMPC)J mutation (2 available); any Bckdhb mutation (21 available)
Data Sources
phenotype observed in females
phenotype observed in males
N normal phenotype
adipose tissue





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/05/2024
MGI 6.24
The Jackson Laboratory